
### [MONDO:0018918](http://purl.obolibrary.org/obo/MONDO_0018918)
**Label:** carcinoma of gallbladder and extrahepatic biliary tract

**Subclasses:** [MONDO:0018536](http://purl.obolibrary.org/obo/MONDO_0018536) (adenocarcinoma of gallbladder and extrahepatic biliary tract), [MONDO:0018537](http://purl.obolibrary.org/obo/MONDO_0018537) (squamous cell carcinoma of gallbladder and extrahepatic biliary tract), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0020566](http://purl.obolibrary.org/obo/MONDO_0020566) (Klatskin tumor), 

**Corr. equiv. classes:** [Orphanet:424996](http://www.orpha.net/ORDO/Orphanet_424996), [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:99978](http://www.orpha.net/ORDO/Orphanet_99978), [OMIM:615619](http://purl.obolibrary.org/obo/OMIM_615619), [Orphanet:424991](http://www.orpha.net/ORDO/Orphanet_424991), 

**Class expressions from DL-Learner:**

- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100871](http://purl.obolibrary.org/obo/HP_0100871) (Abnormality of the palm))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100869](http://purl.obolibrary.org/obo/HP_0100869) (Palmar telangiectasia))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100831](http://purl.obolibrary.org/obo/HP_0100831) (Abnormality of vitamin K metabolism))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100626](http://purl.obolibrary.org/obo/HP_0100626) (Chronic hepatic failure))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100585](http://purl.obolibrary.org/obo/HP_0100585) (Telangiectasia of the skin))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100575](http://purl.obolibrary.org/obo/HP_0100575) (Neoplasm of the gallbladder))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100514](http://purl.obolibrary.org/obo/HP_0100514) (Abnormality of vitamin E metabolism))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100513](http://purl.obolibrary.org/obo/HP_0100513) (Vitamin E deficiency))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100512](http://purl.obolibrary.org/obo/HP_0100512) (Vitamin D deficiency))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100511](http://purl.obolibrary.org/obo/HP_0100511) (Abnormality of vitamin D metabolism))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100508](http://purl.obolibrary.org/obo/HP_0100508) (Abnormality of vitamin metabolism))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100326](http://purl.obolibrary.org/obo/HP_0100326) (Immunologic hypersensitivity))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100281](http://purl.obolibrary.org/obo/HP_0100281) (Chronic colitis))) 70.00%
- [HP:0030153](http://purl.obolibrary.org/obo/HP_0030153) (Cholangiocarcinoma) and (not ([HP:0100279](http://purl.obolibrary.org/obo/HP_0100279) (Ulcerative colitis))) 70.00%


